Literature DB >> 15364051

More sympathy for autoimmunity with neuropeptide Y?

Sammy Bedoui1, Sachiko Miyake, Rainer H Straub, Stephan von Hörsten, Takashi Yamamura.   

Abstract

Substantial evidence indicates a dysfunctional communication between the sympathetic nervous system and the immune system in Th1-mediated autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. In this Opinion, we propose that the sympathetic regulation of immunity is not only mediated by catecholamines but also involves neuropeptide Y (NPY), an additional postganglionic SNS transmitter that is shown to modulate various immunological functions in vitro and in vivo. Based on recent experimental findings, we believe that a more precise understanding of the role of NPY in the regulation of autoimmune Th1 cells will provide novel insights into the neuroimmunological basis of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364051     DOI: 10.1016/j.it.2004.08.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  11 in total

Review 1.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

2.  Autonomic renal denervation ameliorates experimental glomerulonephritis.

Authors:  Roland Veelken; Eva-Maria Vogel; Karl Hilgers; Kerstin Amann; Andrea Hartner; Gabriele Sass; Winfried Neuhuber; Gisa Tiegs
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

3.  NPY and NPY receptors in airway structural and inflammatory cells in allergic asthma.

Authors:  Toluwalope O Makinde; Robert Steininger; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2012-06-12       Impact factor: 3.362

4.  Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia.

Authors:  Raquel Ferreira; Sara Xapelli; Tiago Santos; Ana Paula Silva; Armando Cristóvão; Luísa Cortes; João O Malva
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

5.  Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

Authors:  Suncica Buljevic; Dijana Detel; Lara Baticic Pucar; Radovan Mihelic; Tomislav Madarevic; Branko Sestan; Jadranka Varljen
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

6.  Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells.

Authors:  Raquel Ferreira; Tiago Santos; Michelle Viegas; Luísa Cortes; Liliana Bernardino; Otília V Vieira; João O Malva
Journal:  J Neuroinflammation       Date:  2011-12-02       Impact factor: 8.322

Review 7.  Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis.

Authors:  Paul G Green
Journal:  Arthritis Res Ther       Date:  2005-03-30       Impact factor: 5.156

8.  A fundamental bimodal role for neuropeptide Y1 receptor in the immune system.

Authors:  Julie Wheway; Charles R Mackay; Rebecca A Newton; Amanda Sainsbury; Dana Boey; Herbert Herzog; Fabienne Mackay
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

9.  Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Mohmmad Shoab Mansuri; Mala Singh; Hetanshi H Patel; Nishtha Agarwal; Anish M Shah; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

10.  Serum Neuropeptide Y Levels Are Associated with TNF-α Levels and Disease Activity in Rheumatoid Arthritis.

Authors:  Melissa Ramirez-Villafaña; Ana M Saldaña-Cruz; Javier A Aceves-Aceves; Edsaul E Perez-Guerrero; Nicté S Fajardo-Robledo; Edy D Rubio-Arellano; Cesar A Nava-Valdivia; Maria O Carrillo-Escalante; Sylvia E Totsuka-Sutto; David Cardona-Müller; Betsabe Contreras-Haro; Mario Salazar-Paramo; Ernesto G Cardona-Muñoz; M Huerta; Jorge I Gamez-Nava; Norma A Rodriguez-Jimenez; Laura Gonzalez-Lopez
Journal:  J Immunol Res       Date:  2020-04-16       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.